![]() |
New to the Huntington's Disease Lighthouse? |
||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HD Lighthouse Contributing Editor's Comment:
The paper by Wacker and colleagues (below) does not propose an immediate treatment of HD, but it does shed light on a process that we believe goes to the heart of HD pathology. This process is called oligomerization, which means the clumping together of proteins. In the case of HD, it has been known for some time that the HD protein, huntingtin, tends to oligomerize and to form larger clumps called aggregates or inclusions. Our own experience in modeling huntingtin on computers has led us to believe that the extra stickiness of abnormal huntingtin, which leads to the clumping, has got to be central to HD. If this turns out to indeed be the case, then the insights in this paper may result in therapies that are 1) more effective than those available today or in the near future, e.g., creatine, and 2) closer to being ready than more exotic therapies, e.g., RNA interference.
Huntington's disease, and other neurodegenerative disorders, are known for abnormal protein clumping. In the case of HD, these clumps have been known as aggregates or inclusions. When they were first discovered, aggregates were hailed as the "smoking gun" of HD. They were seen as the perfect therapeutic target: If we could stop aggregation, perhaps we'd have a cure. However, it was soon discovered that aggregates were not always in the sickest cells, and that some of the sickest cells did not even have aggregates. In a few years, it was even suggested that aggregation was a way in which the cell protected itself. What Wacker and colleagues found is that there is another, more microscopic form of clumping. Furthermore, this form, called oligomerization, comes in very characteristic shapes - spherical and doughnut shaped. While this may not sound like such a stunning discovery, it is actually very important, since the same shaped clumps are found in other neurodegenerative diseases, e.g., Alzheimer's disease, Parkinson's disease, etc. And it has been shown in these other diseases that clumps with these shapes are, unlike the aggregates, toxic. Even this much would be an important discovery, since identifying the toxic clumps could aid other researchers in their quest for therapeutics. But the paper goes further. It identifies certain proteins from a class known as heat shock proteins that slow down the creation of these toxic clumps. This is especially exciting to us, since heat shock proteins are from a larger class (molecular chaperones) that help keep proteins in their proper shape (i.e., they keep proteins properly folded). It is well known that the HD protein, huntingtin, has a different shape than the normal version and that this shape makes it stickier, i.e., more likely to clump. Therapeutics similar to the heat shock proteins identified in the paper may, therefore, prevent the clumping and in so doing, prevent or slow down the disease. The fact that a similar clumping occurs in Alzheimer's and Parkinson's is just icing on the cake, since it means that all those researchers who work on those other diseases would also be working for us. So, the paper does two things: 1) It helps bridge a gap in our knowledge - between the shape of huntingtin (Figure 1) and the disease pathology and 2) it suggests a potential source of therapeutics that may go to the heart of the beast.
- image courtesy of MacDonald ME. Huntingtin: alive and well and working in middle management. Sci STKE. 2003 Nov 4;2003(207):pe48. Print 2003 Nov 4. Posted to the HDL: 08 Dec 2004 Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer.Authors:Wacker JL, Zareie MH, Fong H, Sarikaya M, Muchowski PJ Protein conformational changes that result in misfolding, aggregation and amyloid fibril formation are a common feature of many neurodegenerative disorders. Studies with beta-amyloid (Abeta), alpha-synuclein and other amyloid-forming proteins indicate that the assembly of misfolded protein conformers into fibrils is a complex process that may involve the population of metastable spherical and/or annular oligomeric assemblies. Here, we show by atomic force microscopy that a mutant huntingtin fragment with an expanded polyglutamine repeat forms spherical and annular oligomeric structures reminiscent of those formed by Abeta and alpha-synuclein. Notably, the molecular chaperones Hsp70 and Hsp40, which are protective in animal models of neurodegeneration, modulate polyglutamine aggregation reactions by partitioning monomeric conformations and disfavoring the accretion of spherical and annular oligomers. Tracked on the Lighthouse:
Source: Nat Struct Mol Biol. 2004 Nov 14
|
Research focusing on the formation of aggregates caused by HD
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
Research focusing on gene therapy.
Research focusing on gene transcription.
General research related to HD
Research studying the genetics of Huntington's Disease
Research studying the Immune System and it's effect on the progression of HD
Research studying the brain tissue and research related to stem cells
26 Sep 2007
Press release for the BDNF neurogenesis study.
25 Aug 2007
Gene Expression Analysis and Extra-Mitochondrial Energy Metabolism
The HD protein causes a depletion in cellular energy but not through direct effects on the mitochondria, the cell's energy factory.
24 Aug 2007
RE1/NRSE Mediated Gene Transcription
Exciting research suggests that restoring the expression of the genes that the HD protein suppresses could be a major treatment.
20 Aug 2007
The Molecular Zip Code Research Yields a Drug Target
The molecular zip code research suggests that a kinase inhibitor could be a major treatment for Huntington
19 May 2007
D1 receptors and HD
Researchers generated a mouse which progressively lost Dopamine 1 receptor cells and got Huntington's Disease like symptoms.
1 Apr 2007
Copper in the HD brain
Researchers have discovered that excess copper plays a role in Huntington's Disease pathology.
13 Feb 2007
Molecular Zipcodes Provide Address for HD Protein
New findings based on new technology show that the HD protein is being misdirected within the cell. Small molecules are being developed which might place a 'molecular zip code' on the problem.
6 Feb 2007
NCAMs in the HD mice
Problems with NCAMs may explain cognitive and olfactory dysfunction in HD.
19 Dec 2006
Stem Cells and The Aging Brain
Stem cells are still present in the middle aged brain; they just aren't dividing.
8 Dec 2006
ReNeuron Files Application with FDA to Begin Phase I Study of Stem Cell Treatment for Stroke Patients.
A company currently doing stem cell research in animal models of HD, has filed an application with the FDA for permission to begin clinical trials of stem cell treatments for stroke victims.
All Updates for The Brain | |||||||||||||||||||||
| Disclaimer & Privacy
Policy | |
|